Lindsay Kroener1, Daniel Dumesic, Zain Al-Safi. 1. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Abstract
PURPOSE OF REVIEW: There is increasing use of fertility medications for ovulation induction and ovarian stimulation for in-vitro fertilization in the treatment of female infertility. In this review, recent literature regarding the association between fertility medication and cancer risk is reviewed. RECENT FINDINGS: Several important publications have recently addressed the relationship between use of fertility medications and cancer risk. There are methodological limitations to many of these studies, including unique challenges in studying rare cancers that often develop several years after the time of fertility medication exposure. Although infertility per se is a risk factor for some female cancers, including breast, endometrial and ovarian cancer, most studies do not show a significant risk of these cancers with the use of fertility medications. Some studies, however, have shown a possible increased relative risk of borderline ovarian cancer, although the increased absolute risk is small without a clear causal relationship. SUMMARY: The collective data regarding the risk of developing cancer from use of fertility medications are reassuring, although several methodological issues in these studies limit definitive conclusions.
PURPOSE OF REVIEW: There is increasing use of fertility medications for ovulation induction and ovarian stimulation for in-vitro fertilization in the treatment of female infertility. In this review, recent literature regarding the association between fertility medication and cancer risk is reviewed. RECENT FINDINGS: Several important publications have recently addressed the relationship between use of fertility medications and cancer risk. There are methodological limitations to many of these studies, including unique challenges in studying rare cancers that often develop several years after the time of fertility medication exposure. Although infertility per se is a risk factor for some female cancers, including breast, endometrial and ovarian cancer, most studies do not show a significant risk of these cancers with the use of fertility medications. Some studies, however, have shown a possible increased relative risk of borderline ovarian cancer, although the increased absolute risk is small without a clear causal relationship. SUMMARY: The collective data regarding the risk of developing cancer from use of fertility medications are reassuring, although several methodological issues in these studies limit definitive conclusions.
Authors: Alexandra W van den Belt-Dusebout; Mandy Spaan; Cornelis B Lambalk; Marian Kortman; Joop S E Laven; Evert J P van Santbrink; Lucette A J van der Westerlaken; Ben J Cohlen; Didi D M Braat; Jesper M J Smeenk; Jolande A Land; Mariëtte Goddijn; Ron J T van Golde; Minouche M van Rumste; Roel Schats; Katarzyna Józwiak; Michael Hauptmann; Matti A Rookus; Curt W Burger; Flora E van Leeuwen Journal: JAMA Date: 2016-07-19 Impact factor: 56.272
Authors: Alessandra Gennari; Mauro Costa; Matteo Puntoni; Laura Paleari; Andrea De Censi; Maria Pia Sormani; Nicoletta Provinciali; Paolo Bruzzi Journal: Breast Cancer Res Treat Date: 2015-03-06 Impact factor: 4.872
Authors: Albert Asante; Phoebe H Leonard; Amy L Weaver; Ellen L Goode; Jani R Jensen; Elizabeth A Stewart; Charles C Coddington Journal: Fertil Steril Date: 2013-04-01 Impact factor: 7.329
Authors: Sevastiani Antonouli; Maria Grazia Palmerini; Serena Bianchi; Gianna Rossi; Sandra Cecconi; Manuel Belli; Sara Bernardi; Mohammad Ali Khalili; Giuseppe Familiari; Stefania Annarita Nottola; Guido Macchiarelli Journal: J Reprod Dev Date: 2020-04-28 Impact factor: 2.214
Authors: Dariush D Farhud; Shaghayegh Zokaei; Mohammad Keykhaei; Mehdi Hedayati; Marjan Zarif Yeganeh Journal: Iran J Public Health Date: 2021-03 Impact factor: 1.429